56 related articles for article (PubMed ID: 38730240)
1. Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer.
Yang H; Li Q; Chen X; Weng M; Huang Y; Chen Q; Liu X; Huang H; Feng Y; Zhou H; Zhang M; Pei W; Li X; Fu Q; Zhu L; Wang Y; Kong X; Lv K; Zhang Y; Sun Y; Ma M
Nat Commun; 2024 May; 15(1):4296. PubMed ID: 38769295
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 reactivators protect breast cancer cells from ferroptosis.
Rathnayake DS; Dlamini S; Elkalawozgy K; Tillekeratne LMV; Taylor WR
Cell Biochem Funct; 2024 Jun; 42(4):e4036. PubMed ID: 38778584
[TBL] [Abstract][Full Text] [Related]
3. Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis.
Shao L; Zhu L; Su R; Yang C; Gao X; Xu Y; Wang H; Guo C; Li H
Sci Rep; 2024 May; 14(1):10745. PubMed ID: 38730240
[TBL] [Abstract][Full Text] [Related]
4. Transferrin Receptor is Associated with Sensitivity to Ferroptosis Inducers in Hepatocellular Carcinoma.
Hiromatsu M; Toshida K; Itoh S; Harada N; Kohashi K; Oda Y; Yoshizumi T
Ann Surg Oncol; 2023 Dec; 30(13):8675-8689. PubMed ID: 37548836
[TBL] [Abstract][Full Text] [Related]
5. Baicalin enhances the efficacy of 5-Fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis.
Yuan J; Khan SU; Yan J; Lu J; Yang C; Tong Q
Biomed Pharmacother; 2023 Aug; 164():114986. PubMed ID: 37295251
[TBL] [Abstract][Full Text] [Related]
6. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis.
Wen RJ; Dong X; Zhuang HW; Pang FX; Ding SC; Li N; Mai YX; Zhou ST; Wang JY; Zhang JF
Phytomedicine; 2023 Jul; 116():154881. PubMed ID: 37209607
[TBL] [Abstract][Full Text] [Related]
7. Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review.
Ganguly R; Gupta A; Pandey AK
World J Gastroenterol; 2022 Jul; 28(26):3047-3062. PubMed ID: 36051349
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin Triggers Ferroptosis in Multidrug-Resistant Leukemia Cells.
Zhang X; Ai Z; Zhang Z; Dong R; Wang L; Jin S; Wei H
DNA Cell Biol; 2022 Aug; 41(8):705-715. PubMed ID: 35687364
[TBL] [Abstract][Full Text] [Related]
9. SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples.
Ianevski A; Giri AK; Aittokallio T
Nucleic Acids Res; 2022 Jul; 50(W1):W739-W743. PubMed ID: 35580060
[TBL] [Abstract][Full Text] [Related]
10. Exosome-transmitted miR-769-5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53.
Jing X; Xie M; Ding K; Xu T; Fang Y; Ma P; Shu Y
Clin Transl Med; 2022 May; 12(5):e780. PubMed ID: 35522909
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer.
Ouyang S; Li H; Lou L; Huang Q; Zhang Z; Mo J; Li M; Lu J; Zhu K; Chu Y; Ding W; Zhu J; Lin Z; Zhong L; Wang J; Yue P; Turkson J; Liu P; Wang Y; Zhang X
Redox Biol; 2022 Jun; 52():102317. PubMed ID: 35483272
[TBL] [Abstract][Full Text] [Related]
12. Targeting ferroptosis as a vulnerability in cancer.
Lei G; Zhuang L; Gan B
Nat Rev Cancer; 2022 Jul; 22(7):381-396. PubMed ID: 35338310
[TBL] [Abstract][Full Text] [Related]
13. A CGA/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer.
Cao T; Lu Y; Wang Q; Qin H; Li H; Guo H; Ge M; Glass SE; Singh B; Zhang W; Dong J; Du F; Qian A; Tian Y; Wang X; Li C; Wu K; Fan D; Nie Y; Coffey RJ; Zhao X
J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35289315
[TBL] [Abstract][Full Text] [Related]
14. Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axis.
Zhang R; Pan T; Xiang Y; Zhang M; Xie H; Liang Z; Chen B; Xu C; Wang J; Huang X; Zhu Q; Zhao Z; Gao Q; Wen C; Liu W; Ma W; Feng J; Sun X; Duan T; Lai-Han Leung E; Xie T; Wu Q; Sui X
Bioact Mater; 2022 Jul; 13():23-36. PubMed ID: 35224289
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance.
Zhang C; Liu X; Jin S; Chen Y; Guo R
Mol Cancer; 2022 Feb; 21(1):47. PubMed ID: 35151318
[TBL] [Abstract][Full Text] [Related]
16. Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1.
Kong N; Chen X; Feng J; Duan T; Liu S; Sun X; Chen P; Pan T; Yan L; Jin T; Xiang Y; Gao Q; Wen C; Ma W; Liu W; Zhang M; Yang Z; Wang W; Zhang R; Chen B; Xie T; Sui X; Tao W
Acta Pharm Sin B; 2021 Dec; 11(12):4045-4054. PubMed ID: 35024325
[TBL] [Abstract][Full Text] [Related]
17. Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer.
Kim R; An M; Lee H; Mehta A; Heo YJ; Kim KM; Lee SY; Moon J; Kim ST; Min BH; Kim TJ; Rha SY; Kang WK; Park WY; Klempner SJ; Lee J
Cancer Discov; 2022 Apr; 12(4):984-1001. PubMed ID: 34933901
[TBL] [Abstract][Full Text] [Related]
18. Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m
Jiang H; Yao Q; An Y; Fan L; Wang J; Li H
Phytomedicine; 2022 Jan; 94():153823. PubMed ID: 34763315
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
